↓ Skip to main content

mRNA therapeutics in cancer immunotherapy

Overview of attention for article published in Molecular Cancer, April 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 1,940)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
24 news outlets
blogs
1 blog
policy
1 policy source
twitter
48 X users
patent
2 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
173 Dimensions

Readers on

mendeley
398 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
mRNA therapeutics in cancer immunotherapy
Published in
Molecular Cancer, April 2021
DOI 10.1186/s12943-021-01348-0
Pubmed ID
Authors

Jan D. Beck, Daniel Reidenbach, Nadja Salomon, Ugur Sahin, Özlem Türeci, Mathias Vormehr, Lena M. Kranz

X Demographics

X Demographics

The data shown below were collected from the profiles of 48 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 398 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 398 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 54 14%
Researcher 48 12%
Student > Ph. D. Student 40 10%
Student > Master 25 6%
Other 13 3%
Other 39 10%
Unknown 179 45%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 75 19%
Pharmacology, Toxicology and Pharmaceutical Science 29 7%
Immunology and Microbiology 24 6%
Medicine and Dentistry 17 4%
Agricultural and Biological Sciences 16 4%
Other 52 13%
Unknown 185 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 233. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2023.
All research outputs
#164,441
of 25,584,565 outputs
Outputs from Molecular Cancer
#5
of 1,940 outputs
Outputs of similar age
#5,029
of 456,450 outputs
Outputs of similar age from Molecular Cancer
#1
of 29 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,940 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,450 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.